GO:0055088 lipid homeostasis: Regulation, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0055088 lipid homeostasis is the biological process that maintains a steady internal state of lipids within a cell or organism, balancing synthesis, uptake, storage, export, and degradation.
• SREBP transcription factors (SREBF1/SREBP-1 and SREBF2) are master regulators that coordinate lipid synthesis and lipophagy to preserve lipid homeostasis.
• Hepatic lipid homeostasis depends on autophagy-related pathways, including spliceosome component Usp39 and Orosomucoid 2 (ORM2)-mediated suppression of de novo lipogenesis.
• Receptor-mediated ER export of lipoproteins is essential for systemic lipid homeostasis in mice and humans.
• Disruption of lipid homeostasis contributes to cancer, diabetic nephropathy, metabolic dysfunction, and lipotoxicity-related diseases.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal testing of lipid homeostasis genes in relevant cell types.
Description
Lipid homeostasis (GO:0055088) is a fundamental biological process defined as any process involved in the maintenance of an internal steady state of lipid within an organism or cell. This term encompasses the coordinated regulation of lipid synthesis, uptake, storage, trafficking, and degradation, ensuring that cellular lipid levels remain within physiological limits. Because lipids serve as membrane building blocks, signaling molecules, and energy stores, their imbalance is linked to a broad spectrum of diseases, including cancer, metabolic disorders, and organ-specific pathologies. Researchers study lipid homeostasis to understand how cells adapt to nutritional and metabolic stress, and to identify therapeutic targets that restore lipid balance. The process is orchestrated by transcription factors, autophagy machinery, secreted proteins, and lipoprotein trafficking pathways, making it a rich area for CRISPR-based functional genomics.
lipid homeostasis At A Glance
| GO ID | GO:0055088 |
|---|---|
| GO term | lipid homeostasis |
| Ontology | biological_process |
| Synonym | none |
| Definition | Any process involved in the maintenance of an internal steady state of lipid within an organism or cell. |
| Major function | Maintains stable cellular and organismal lipid levels by balancing synthesis, uptake, storage, export, and degradation. |
| Key regulators | SREBP transcription factors (SREBF1/SREBP-1, SREBF2), autophagy components, and secreted metabolic proteins. |
| Associated diseases | Cancer, diabetic nephropathy, metabolic dysfunction, and lipotoxicity-related pathologies. |
| Research methods | CRISPR knockout, point mutation, knock-in, overexpression, lipidomics, and autophagy flux assays. |
What Is GO:0055088?
In our own words, GO:0055088 lipid homeostasis refers to the collection of cellular and organismal processes that keep the internal amount and composition of lipids stable over time. It includes sensing lipid levels, adjusting synthesis and breakdown, storing excess lipids safely, and mobilizing them when needed. This definition is based on the QuickGO entry for GO:0055088, which states: Any process involved in the maintenance of an internal steady state of lipid within an organism or cell.
Why Is lipid homeostasis Important in Cell Biology?
Lipid homeostasis is important because every cell must balance lipid synthesis, storage, and utilization to survive metabolic stress, and failure of this balance leads to lipotoxicity, organ dysfunction, and disease progression. The process is central to cancer cell growth, hepatic metabolism, renal function, and systemic lipoprotein transport, making it a high-value target for both mechanistic studies and therapeutic development.
• Maintains membrane integrity and signaling lipid pools required for cell survival.
• Prevents lipotoxicity caused by excess free fatty acids and lipid intermediates.
• Supports tumor growth by supplying lipids for proliferation and by regulating lipophagy.
• Controls hepatic lipid balance through autophagy and suppression of de novo lipogenesis.
• Regulates systemic lipid transport via receptor-mediated ER export of lipoproteins.
• Is disrupted in diabetic nephropathy, contributing to lipid accumulation and mitochondrial dysfunction.
• Couples daily sleep and neuron-glia metabolic cycles to mitochondrial homeostasis.
• Provides targets for CRISPR screens aimed at discovering metabolic vulnerabilities.
• Informs development of therapies for metabolic and cardiovascular diseases.
• Serves as a model process for studying organelle crosstalk and stress adaptation.
What Happens During lipid homeostasis?
Lipid sensing and transcriptional control
In simple terms: Cells first check how much lipid they have and then adjust gene expression accordingly.
Lipid homeostasis begins with sensing of lipid levels, which is largely mediated by SREBP transcription factors. SREBP transcription factors act as master regulators of lipid homeostasis by activating genes required for cholesterol and fatty acid synthesis when lipid levels are low. SREBF1/SREBP-1 concurrently regulates lipid synthesis and lipophagy, thereby maintaining lipid homeostasis and supporting tumor growth. This transcriptional layer ensures that lipid production matches cellular demand.
Lipid synthesis and de novo lipogenesis
In simple terms: When lipids are scarce, cells build new lipids from simpler precursors.
De novo lipogenesis is a core arm of lipid homeostasis. Orosomucoid 2 (ORM2) maintains hepatic lipid homeostasis through suppression of de novo lipogenesis, indicating that secreted proteins can restrain lipid synthesis in the liver. SREBP-1 drives expression of lipogenic enzymes, and its activity is tightly coupled to the lipid state of the cell.
Autophagy and lipophagy
In simple terms: Cells can recycle their own lipid stores by digesting them through autophagy.
Autophagy contributes to lipid homeostasis by degrading lipid droplets and other lipid-containing structures. The spliceosome component Usp39 contributes to hepatic lipid homeostasis through the regulation of autophagy. SREBF1/SREBP-1 also regulates lipophagy, linking transcriptional control to autophagic lipid turnover. This ensures that excess or damaged lipids are cleared when needed.
Lipoprotein export and systemic transport
In simple terms: Lipids are packaged and shipped out of cells to reach other tissues.
Receptor-mediated ER export of lipoproteins controls lipid homeostasis in mice and humans, demonstrating that intracellular trafficking of lipoprotein particles is essential for systemic lipid balance. This step connects cellular lipid handling to whole-body lipid distribution.
Mitochondrial and organelle crosstalk
In simple terms: Lipids must be coordinated with mitochondria and other organelles to keep the cell healthy.
Metrnl alleviates lipid accumulation by modulating mitochondrial homeostasis in diabetic nephropathy, showing that mitochondrial function is intertwined with lipid homeostasis. A neuron-glia lipid metabolic cycle couples daily sleep to mitochondrial homeostasis, further illustrating how lipid homeostasis integrates with organelle and physiological rhythms.
Key Genes Involved in GO:0055088 lipid homeostasis
The following genes and proteins are experimentally implicated in lipid homeostasis (GO:0055088) based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SREBF1 | Encodes SREBP-1, a master transcription factor regulating lipid synthesis and lipophagy | Central regulator of lipid homeostasis and tumor growth; frequent target in metabolic and cancer studies |
| SREBF2 | Encodes SREBP-2, a transcription factor controlling cholesterol-related lipid homeostasis | Key node in cholesterol and lipid homeostasis research |
| USP39 | Spliceosome component that contributes to hepatic lipid homeostasis through autophagy regulation | Links RNA splicing to hepatic lipid metabolism and autophagy |
| ORM2 | Orosomucoid 2 suppresses de novo lipogenesis to maintain hepatic lipid homeostasis | Secreted factor with therapeutic potential in hepatic lipid disorders |
| METRNL | Alleviates lipid accumulation by modulating mitochondrial homeostasis in diabetic nephropathy | Candidate target for diabetic kidney disease and lipid accumulation |
| SREBP-1 | Protein product of SREBF1; concurrently regulates lipid synthesis and lipophagy | Direct effector of lipid homeostasis and autophagy crosstalk |
| SREBP-2 | Protein product of SREBF2; master regulator of lipid homeostasis | Core transcription factor in lipid homeostasis |
| Autophagy machinery genes | Mediate lipophagy and autophagic lipid turnover | Functional readouts for lipid homeostasis studies |
| Lipoprotein export receptors | Mediate receptor-mediated ER export of lipoproteins | Essential for systemic lipid homeostasis in mice and humans |
| Mitochondrial homeostasis genes | Support mitochondrial function linked to lipid handling | Relevant to diabetic nephropathy and sleep-metabolism coupling |
| Neuron-glia metabolic cycle genes | Couple daily sleep to mitochondrial and lipid homeostasis | Model for intercellular lipid metabolic cycles |
| Lipotoxicity regulators | Emerging regulators of lipotoxicity in health and disease | Broad relevance to metabolic and cardiovascular disease |
| De novo lipogenesis enzymes | Catalyze fatty acid synthesis suppressed by ORM2 | Targets for hepatic lipid homeostasis modulation |
| Spliceosome components | Influence autophagy and hepatic lipid homeostasis | Emerging link between RNA processing and lipid metabolism |
| ER export machinery | Controls lipoprotein trafficking and lipid homeostasis | Potential target for dyslipidemia research |
| Lipophagy regulators | Control autophagic degradation of lipids | Key effectors downstream of SREBP-1 |
How Is lipid homeostasis Regulated?
Lipid homeostasis is regulated at multiple levels. Transcriptionally, SREBP transcription factors act as master regulators that adjust lipid synthesis gene programs in response to lipid status. SREBF1/SREBP-1 concurrently regulates lipid synthesis and lipophagy, providing a dual control mechanism that balances production and degradation of lipids. Post-transcriptionally, spliceosome component Usp39 contributes to hepatic lipid homeostasis through the regulation of autophagy, linking RNA processing to autophagic lipid turnover. Secreted factors such as Orosomucoid 2 suppress de novo lipogenesis to maintain hepatic lipid homeostasis. At the organelle level, mitochondrial homeostasis modulates lipid accumulation, as shown for Metrnl in diabetic nephropathy, and neuron-glia metabolic cycles couple sleep to mitochondrial and lipid homeostasis. Receptor-mediated ER export of lipoproteins further regulates systemic lipid homeostasis.
lipid homeostasis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SREBF1 | Cancer and tumor growth via lipid synthesis and lipophagy | Knockout and overexpression in cancer cell lines; lipophagy flux assays |
| METRNL | Diabetic nephropathy with lipid accumulation | Knockout and overexpression in renal cells; mitochondrial function assays |
| USP39 | Hepatic lipid homeostasis and autophagy dysregulation | Liver-specific knockout; autophagy flux and lipidomics |
| ORM2 | Hepatic lipid disorders via de novo lipogenesis | Overexpression and knockout in hepatocytes; lipogenesis assays |
| Lipoprotein export receptors | Systemic lipid homeostasis in mice and humans | Knock-in and knockout mouse models; lipoprotein trafficking assays |
Cancer and tumor growth
SREBF1/SREBP-1 concurrently regulates lipid synthesis and lipophagy to maintain lipid homeostasis and tumor growth, indicating that cancer cells depend on lipid homeostasis for proliferation and survival. SREBP transcription factors are master regulators of lipid homeostasis, and their dysregulation can support oncogenic metabolic reprogramming.
Diabetic nephropathy and metabolic kidney disease
Metrnl alleviates lipid accumulation by modulating mitochondrial homeostasis in diabetic nephropathy, linking lipid homeostasis to kidney injury in diabetes. This suggests that restoring lipid homeostasis may protect renal function under diabetic conditions.
Hepatic lipid disorders and metabolic dysfunction
Usp39 contributes to hepatic lipid homeostasis through autophagy regulation, and Orosomucoid 2 maintains hepatic lipid homeostasis by suppressing de novo lipogenesis. These findings connect lipid homeostasis to liver metabolic health and potential therapeutic strategies.
Lipotoxicity and systemic metabolic disease
Lipid metabolism in sickness and in health involves emerging regulators of lipotoxicity, highlighting how loss of lipid homeostasis contributes to cellular damage and disease. Receptor-mediated ER export of lipoproteins controls lipid homeostasis in mice and humans, linking trafficking defects to systemic lipid disorders.
From lipid homeostasis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is SREBF1 required for lipid homeostasis and tumor growth? | CRISPR knockout of SREBF1 in cancer cell lines |
| Does SREBP-1 simultaneously control lipid synthesis and lipophagy? | Point-mutation or knockout of SREBF1 with lipophagy flux readouts |
| Can ORM2 suppression of de novo lipogenesis be enhanced? | Overexpression of ORM2 in hepatocytes |
| Does Usp39 regulate hepatic lipid homeostasis through autophagy? | Liver-specific knockout of Usp39 with autophagy markers |
| How does Metrnl modulate mitochondrial homeostasis in diabetic nephropathy? | Knockout and overexpression of METRNL in renal cells |
| Is receptor-mediated ER export required for systemic lipid homeostasis? | Knock-in or knockout of lipoprotein export receptors in mice |
How to Study the lipid homeostasis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Lipidomics / mass spectrometry | Abundance and composition of lipid species | Assessing lipid homeostasis disruption in cells and tissues |
| Autophagy flux assay | Autophagic degradation and lipophagy activity | Testing Usp39 or SREBF1 effects on lipid turnover |
| SREBP reporter assay | Transcriptional activity of SREBP factors | Measuring lipid homeostasis regulatory input |
| RNA-seq | Global gene expression changes | Identifying lipogenic and autophagic programs |
| Mitochondrial function assay | Mitochondrial respiration and homeostasis | Studying Metrnl and lipid accumulation in diabetic nephropathy |
| Imaging of lipid droplets | Number, size, and distribution of lipid stores | Visualizing lipid homeostasis phenotypes |
| Lipoprotein trafficking assay | ER export and secretion of lipoproteins | Evaluating systemic lipid homeostasis |
| CRISPR knockout screening | Gene requirement for lipid homeostasis | Discovering novel regulators of lipid balance |
Lipidomics and mass spectrometry
Lipidomics measures the abundance and composition of lipid species to assess whether lipid homeostasis is maintained or disrupted. This approach is essential for quantifying changes in fatty acids, phospholipids, and storage lipids in cells and tissues.
Autophagy and lipophagy flux assays
Because autophagy contributes to lipid homeostasis, flux assays monitor autophagic degradation of lipid droplets and autophagosome turnover. These assays are used to test whether genes such as Usp39 or SREBF1 affect lipophagy.
Transcriptional and reporter assays
SREBP transcription factors are master regulators of lipid homeostasis, so reporter assays and target gene expression profiling are used to measure SREBP activity and downstream lipogenic programs. These methods help determine whether a gene of interest feeds into SREBP-driven lipid homeostasis.
Mitochondrial function and imaging
Mitochondrial homeostasis is coupled to lipid handling, so mitochondrial function assays and imaging are used to evaluate lipid accumulation and organelle health. Such methods have been applied to study Metrnl in diabetic nephropathy and neuron-glia lipid metabolic cycles.
How CRISPR Can Be Used to Study GO:0055088 lipid homeostasis
Knockout
CRISPR knockout is used to delete genes such as SREBF1, USP39, or METRNL to test whether they are required for lipid homeostasis. For example, knockout of SREBF1 can reveal its essential role in lipid synthesis and lipophagy during tumor growth, while Usp39 knockout can assess hepatic lipid homeostasis through autophagy.
Point Mutation
Point mutation models introduce specific amino acid changes to dissect functional domains of lipid homeostasis regulators. This is useful for separating the lipid synthesis and lipophagy functions of SREBP-1 or for testing phosphorylation and regulatory sites in SREBP transcription factors.
Knock-in
Knock-in models add tags or disease-relevant variants to endogenous loci, enabling tracking of proteins involved in lipid homeostasis. Tagged knock-in of SREBP-1 or lipoprotein export receptors allows visualization of their trafficking and dynamics in living cells.
Overexpression
Overexpression models test whether increasing a gene product is sufficient to alter lipid homeostasis. Overexpression of ORM2 suppresses de novo lipogenesis and maintains hepatic lipid homeostasis, while overexpression of METRNL alleviates lipid accumulation in diabetic nephropathy.
How EDITGENE Supports lipid homeostasis Research
Researchers studying lipid homeostasis-related genes often need to determine whether a candidate gene is causally involved in maintaining lipid balance or is merely correlated with metabolic changes. CRISPR-based models provide the controlled perturbations required to establish causality, and EDITGENE offers a comprehensive platform for generating and screening such models.
Contact EDITGENE today to design your custom CRISPR model for lipid homeostasis research.
Frequently Asked Questions About lipid homeostasis
What is lipid homeostasis GO:0055088?
GO:0055088 lipid homeostasis is the biological process that maintains an internal steady state of lipid within an organism or cell, balancing lipid synthesis, uptake, storage, export, and degradation.
What genes are involved in lipid homeostasis?
Key genes include SREBF1 and SREBF2, which encode master transcription factors, as well as USP39, ORM2, and METRNL, which regulate autophagy, de novo lipogenesis, and mitochondrial homeostasis respectively.
How is lipid homeostasis regulated?
It is regulated transcriptionally by SREBP factors, post-transcriptionally by spliceosome components such as Usp39, and through secreted factors like ORM2 that suppress de novo lipogenesis.
Why is lipid homeostasis important in cancer?
SREBF1/SREBP-1 concurrently regulates lipid synthesis and lipophagy to maintain lipid homeostasis and tumor growth, making it essential for cancer cell proliferation.
What diseases are linked to lipid homeostasis disruption?
Disruption is linked to cancer, diabetic nephropathy, hepatic lipid disorders, lipotoxicity, and systemic metabolic disease.
How do researchers study lipid homeostasis?
They use lipidomics, autophagy flux assays, SREBP reporter assays, RNA-seq, mitochondrial function assays, and CRISPR knockout or overexpression models.
What is the role of SREBP in lipid homeostasis?
SREBP transcription factors are master regulators of lipid homeostasis, controlling genes for lipid synthesis and, in the case of SREBP-1, also lipophagy.
Can CRISPR be used to study lipid homeostasis?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of genes such as SREBF1, USP39, ORM2, and METRNL in lipid homeostasis.
What is lipophagy and how does it relate to lipid homeostasis?
Lipophagy is the autophagic degradation of lipids, and it is regulated by SREBF1/SREBP-1 as part of the lipid homeostasis process.
Which experimental models are best for lipid homeostasis research?
Relevant models include liver-specific knockouts for hepatic lipid homeostasis, renal cell models for diabetic nephropathy, and cancer cell lines for SREBP-driven lipid synthesis.
Conclusion
GO:0055088 lipid homeostasis is a central biological process that integrates transcriptional control by SREBP factors, autophagic lipid turnover, secreted metabolic regulators, and organelle crosstalk to maintain stable lipid levels. Its disruption underlies cancer, diabetic nephropathy, hepatic lipid disorders, and lipotoxicity, making it a high-priority area for mechanistic and therapeutic research. CRISPR-based knockout, point-mutation, knock-in, and overexpression models, combined with lipidomics and autophagy assays, provide the tools needed to dissect causal roles of lipid homeostasis genes and to identify new targets for intervention.
References
- 1. Geng F et al.. 2024. SREBF1/SREBP-1 concurrently regulates lipid synthesis and lipophagy to maintain lipid homeostasis and tumor growth.. Autophagy 20(5):1183-1185 PMID: 37927089
- 2. Eberlé D et al.. 2004. SREBP transcription factors: master regulators of lipid homeostasis.. Biochimie 86(11):839-48 PMID: 15589694
- 3. Zhou Y et al.. 2023. Metrnl Alleviates Lipid Accumulation by Modulating Mitochondrial Homeostasis in Diabetic Nephropathy.. Diabetes 72(5):611-626 PMID: 36812572
- 4. Cui D et al.. 2023. Spliceosome component Usp39 contributes to hepatic lipid homeostasis through the regulation of autophagy.. Nat Commun 14(1):7032 PMID: 37923718
- 5. Zhou B et al.. 2022. Orosomucoid 2 maintains hepatic lipid homeostasis through suppression of de novo lipogenesis.. Nat Metab 4(9):1185-1201 PMID: 36050503
- 6. Yoon H et al.. 2021. Lipid metabolism in sickness and in health: Emerging regulators of lipotoxicity.. Mol Cell 81(18):3708-3730 PMID: 34547235
- 7. Haynes PR et al.. 2024. A neuron-glia lipid metabolic cycle couples daily sleep to mitochondrial homeostasis.. Nat Neurosci 27(4):666-678 PMID: 38360946
- 8. Wang X et al.. 2021. Receptor-Mediated ER Export of Lipoproteins Controls Lipid Homeostasis in Mice and Humans.. Cell Metab 33(2):350-366.e7 PMID: 33186557
